Clinical variability in CILK1-related CED, with differing liver or skeletal predominance, likely reflects genetic modifiers (e.g., IFT122, IFT52, GLI3) or environmental factors, although no explicit pathogenic modifiers were identified in our cohort. This evidence concerns the gene GLI3 and cranioectodermal dysplasia.